These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7726592)

  • 1. Adverse drug interactions clinically important for the dermatologist.
    Andersen WK; Feingold DS
    Arch Dermatol; 1995 Apr; 131(4):468-73. PubMed ID: 7726592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug interactions in dermatological practice.
    Tey HL; Tian EL; Tan AW
    Clin Exp Dermatol; 2008 Aug; 33(5):541-50. PubMed ID: 18801094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse drug reactions to antibiotics and major antibiotic drug interactions.
    Novotný J; Novotný M
    Gen Physiol Biophys; 1999 Oct; 18 Spec No():126-39. PubMed ID: 10703731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventing dangerous drug interactions.
    Piscitelli S
    J Am Pharm Assoc (Wash); 2000; 40(5 Suppl 1):S44-5. PubMed ID: 11029865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinically important potential drug-drug interactions in outpatient settings.
    Aparasu R; Baer R; Aparasu A
    Res Social Adm Pharm; 2007 Dec; 3(4):426-37. PubMed ID: 18082877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral antibiotic drug interactions of clinical significance to dermatologists.
    Del Rosso JQ
    Dermatol Clin; 2009 Jan; 27(1):91-4. PubMed ID: 18984372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinically significant drug interactions.
    Ament PW; Bertolino JG; Liszewski JL
    Am Fam Physician; 2000 Mar; 61(6):1745-54. PubMed ID: 10750880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinically significant" new drug interactions].
    Fuhr U
    Med Klin (Munich); 2000 May; 95(1 Spec No):18-22. PubMed ID: 10851844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinically significant therapeutic interactions for the practicing dermatologist.
    Lebwohl M; Gelfand JM; Tan MH
    Adv Dermatol; 1999; 14():1-26; discussion 27. PubMed ID: 10643493
    [No Abstract]   [Full Text] [Related]  

  • 11. Concurrent prescribing. Beware of drug interactions.
    Munckhof WJ
    Aust Fam Physician; 1998 Oct; 27(10):895-901. PubMed ID: 9798287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avoiding drug interactions.
    Prescrire Int; 2004 Jun; 13(71):99-102. PubMed ID: 15233147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of high-risk use of QT-prolonging medications.
    Allen LaPointe NM; Curtis LH; Chan KA; Kramer JM; Lafata JE; Gurwitz JH; Raebel MA; Platt R
    Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):361-8. PubMed ID: 16178046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug interactions as a cause of drug side effects].
    Meier-Abt PJ; Meier C
    Ther Umsch; 1993 Jan; 50(1):42-8. PubMed ID: 8378866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of potential azole drug-drug interactions and consequences of potential fluconazole drug interactions.
    Yu DT; Peterson JF; Seger DL; Gerth WC; Bates DW
    Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):755-67. PubMed ID: 15654717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication errors: an analysis comparing PHICO's closed claims data and PHICO's Event Reporting Trending System (PERTS).
    Benjamin DM; Pendrak RF
    J Clin Pharmacol; 2003 Jul; 43(7):754-9. PubMed ID: 12856390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse drug reactions: types and treatment options.
    Riedl MA; Casillas AM
    Am Fam Physician; 2003 Nov; 68(9):1781-90. PubMed ID: 14620598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrepancies in reported drug use in geriatric outpatients: relevance to adverse events and drug-drug interactions.
    Tulner LR; Kuper IM; Frankfort SV; van Campen JP; Koks CH; Brandjes DP; Beijnen JH
    Am J Geriatr Pharmacother; 2009 Apr; 7(2):93-104. PubMed ID: 19447362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug interactions].
    Orzechowska-Juzwenko K
    Pol Merkur Lekarski; 2000 Sep; 9(51):593-4. PubMed ID: 11126980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug combinations and potential for risk of adverse drug reaction among community-dwelling elderly.
    Pollow RL; Stoller EP; Forster LE; Duniho TS
    Nurs Res; 1994; 43(1):44-9. PubMed ID: 8295840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.